These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 26943814)

  • 1. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma.
    Qiu K; Huang Z; Huang Z; He Z; You S
    Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of miR-21 in proliferation and invasion capacity of human tongue squamous cell carcinoma in vitro.
    Wang Y; Zhu Y; Lv P; Li L
    Int J Clin Exp Pathol; 2015; 8(5):4555-63. PubMed ID: 26191145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.
    Wei T; Cong X; Wang XT; Xu XJ; Min SN; Ye P; Peng X; Wu LL; Yu GY
    Oncotarget; 2017 Jan; 8(4):6663-6680. PubMed ID: 28035060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cantharidin inhibits cell proliferation and promotes apoptosis in tongue squamous cell carcinoma through suppression of miR-214 and regulation of p53 and Bcl-2/Bax.
    Tian X; Zeng G; Li X; Wu Z; Wang L
    Oncol Rep; 2015 Jun; 33(6):3061-8. PubMed ID: 25962755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-25-3p attenuates the proliferation of tongue squamous cell carcinoma cell line Tca8113.
    Xu JY; Yang LL; Ma C; Huang YL; Zhu GX; Chen QL
    Asian Pac J Trop Med; 2013 Sep; 6(9):743-7. PubMed ID: 23827155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermia inhibited the migration of tongue squamous cell carcinoma through TWIST2.
    Tang YL; Jiang J; Liu J; Zheng M; He YW; Chen W; Fan YL; Chen QM; Liao CH; Liang XH
    J Oral Pathol Med; 2015 May; 44(5):337-44. PubMed ID: 25048179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
    Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
    BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-611 promotes the proliferation, migration and invasion of tongue squamous cell carcinoma cells by targeting FOXN3.
    Chen S; Zhang J; Sun L; Li X; Bai J; Zhang H; Li T
    Oral Dis; 2019 Nov; 25(8):1906-1918. PubMed ID: 31419344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7.
    Zhao J; Hu C; Chi J; Li J; Peng C; Yun X; Li D; Yu Y; Li Y; Gao M; Zheng X
    Oncol Rep; 2016 Aug; 36(2):1143-9. PubMed ID: 27350307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2.
    Ding J; Yang C; Yang S
    J Oral Pathol Med; 2018 May; 47(5):468-476. PubMed ID: 29315846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.
    Li D; Liu K; Li Z; Wang J; Wang X
    Cell Adh Migr; 2018 May; 12(3):236-246. PubMed ID: 29130787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.
    Yu B; Zhang Y; Wu K; Wang L; Jiang Y; Chen W; Yan M
    J Cell Mol Med; 2019 Feb; 23(2):954-966. PubMed ID: 30421493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion.
    Sun L; Liang J; Wang Q; Li Z; Du Y; Xu X
    Cell Prolif; 2016 Oct; 49(5):628-35. PubMed ID: 27571935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting miR-21 with AS-miR-21 suppresses aggressive growth of human tongue squamous cell carcinoma in vivo.
    Wang Y; Zhu Y; Lv P; Li L
    Int J Clin Exp Pathol; 2015; 8(5):4773-81. PubMed ID: 26191167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.
    Kinoshita T; Hanazawa T; Nohata N; Kikkawa N; Enokida H; Yoshino H; Yamasaki T; Hidaka H; Nakagawa M; Okamoto Y; Seki N
    Oncotarget; 2012 Nov; 3(11):1386-400. PubMed ID: 23159910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14.
    Jia LF; Wei SB; Mitchelson K; Gao Y; Zheng YF; Meng Z; Gan YH; Yu GY
    PLoS One; 2014; 9(9):e108435. PubMed ID: 25268950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.
    Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ
    Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNHG1/miR-194-5p/MTFR1 Axis Promotes TGFβ1-Induced EMT, Migration and Invasion of Tongue Squamous Cell Carcinoma Cells.
    Jia Y; Chen X; Zhao D; Ma S
    Mol Biotechnol; 2022 Jul; 64(7):780-790. PubMed ID: 35107755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MiR-125b-5 suppresses ovarian cancer cell migration and invasion by targeted downregulation of CD147].
    Huang Z; Shen H; Deng H; Sun L; Qü B
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Sep; 42(9):1389-1396. PubMed ID: 36210713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.